Get startedLog in
    Picture of Swedish Orphan Biovitrum AB (publ) logo

    SOBI — Swedish Orphan Biovitrum AB (publ) News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareBalancedLarge CapHigh Flyer
    All News

    Brief: Swedish Orphan Biovitrum To Amend Agreement With Apellis

    Picture of Swedish Orphan Biovitrum AB (publ) logoSwedish Orphan Biovitrum AB (publ)
    01/07/2025 14:36
    July 1 (Reuters) - Swedish Orphan Biovitrum AB (publ) SOBIV.ST:

TO AMEND EXISTING AGREEMENT WITH APELLIS FOR EX-U.S. ROYALTIES OF ASPAVELI®

SOBI ANNOUNCES CAPPED ROYALTY PURCHASE AGREEMENT WITH APELLIS

SOBI TO PAY $275 MILLION UPFRONT AND UP TO $25 MILLION IN MILESTONES

Source text: ID:nWkr15Lnly

Further company coverage: SOBIV.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

    Recent news on Swedish Orphan Biovitrum AB (publ)

    See all news